Skip to main content

Table 3 Distribution of the variables regarding primary dysmenorrhoea as the outcome

From: Prevalence of chronic pelvic pain and primary dysmenorrhea in women of reproductive age in Ecuador

 

N (%)

Control

Dysmenorrhoea

PR

CI 95%

 

(n = 2,184)

(n = 213)

inf

sup

Age, y

      

 < 20

363 (15.1)

324 (14.8)

39 (18.3)

1.21

0.86

1.70

 20–35

1455 (60.7)

1326 (60.7)

129 (60.6)

1.00

1.00

1.00

 > 35

579 (24.2)

534 (24.4)

45 (21.1)

0.88

0.63

1.21

Body mass index, Kg·m−2

      

 < 25

1457 (60.8)

1339 (61.3)

118 (55.4)

1.00

1.00

1.00

 25–30

731 (30.5)

663 (30.4)

68 (31.9)

1.15

0.86

1.53

 > 30

209 (8.7)

182 (8.3)

27 (12.7)

1.60

1.08

2.36

Marital status

      

 Married/stable union

1486 (62.0)

1358 (62.2)

128 (60.1)

1.00

1.00

1.00

 Single, widow

829 (34.6)

751 (34.4)

78 (36.6)

1.09

0.84

1.43

 Divorced

80 (3.3)

73 (3.4)

7 (3.3)

1.02

0.49

2.10

Educational level

      

 Low (< 8 years)

266 (11.1)

247 (11.4)

19 (8.9)

0.75

0.47

1.19

 Intermediate (8–12 years)

1515 (63.4)

1371 (63.0)

144 (67.6)

1.00

1.00

1.00

 High (> 12 years)

609 (25.5)

559 (25.7)

50 (23.5)

0.86

0.64

1.18

Occupation

      

 Employee

1019 (42.7)

922 (42.4)

97 (45.5)

1.00

1.00

1.00

 Housewife

301 (12.6)

275 (12.6)

26 (12.2)

0.91

0.60

1.37

 In education

985 (41.3)

899 (41.4)

86 (40.4)

0.92

0.70

1.21

 Unemployed

82 (3.4)

78 (3.6)

4 (1.9)

0.51

0.19

1.36

Remuneration

1121 (46.8)

1020 (46.8)

101 (47.4)

0.98

0.76

1.26

Physical activity

979 (40.9)

889 (40.7)

90 (42.2)

1.06

0.82

1.37

Religious practice

1698 (70.9)

1544(70.7)

154 (72.3)

1.07

0.80

1.43

Smoking

474 (19.8)

414 (19.0)

60 (28.2)

1.59

1.20

2.11

Alcohol use disorder

1358 (56.6)

1227 (56.2)

131 (61.5)

1.22

0.94

1.59

Illicit drug use

131 (5.5)

111 (5.1)

20 (9.4)

1.79

1.17

2.74

Violence victim

565 (23.6)

486 (22.2)

79 (37.1)

1.91

1.47

2.48

Abdominal surgery

668 (27.9)

592 (27.1)

76 (35.7)

1.44

1.11

1.88

Contraceptive use

620 (25.9)

567 (26.0)

53 (24.9)

0.95

0.71

1.28

Abnormal menstruation

431 (18.0)

381 (17.4)

50 (23.5)

1.40

1.04

1.89

Previous sexual intercourse

1909 (79.6)

1727 (79.1)

182 (85.4)

1.50

1.04

2.17

Parity

      

 0

1224 (51.1)

1114 (51.0)

110 (51.6)

1.00

1.00

1.00

 1–2

752 (31.4)

675 (30.9)

77 (36.2)

1.08

0.73

1.60

 3 + 

411 (17.2)

372 (17.2)

49 (17.0)

1.35

0.88

2.07

Dyspareunia

210 (16.2)

170 (14.6)

40 (30.8)

2.30

1.63

3.24

Cardiovascular disease

142 (5.9)

130 (6.0)

12 (5.6)

0.95

0.54

1.66

Diabetes

33 (1.4)

27 (1.2)

6 (2.8)

2.08

1.00

4.33

Respiratory disease

176 (7.3)

154 (7.0)

22 (10.3)

1.45

0.96

2.20

Cancer

17 (0.7)

17 (0.8)

0 (0.0)

–

–

–

Psychiatric disorder

77 (3.2)

66 (3.0)

11 (5.2)

1.64

0.94

2.88

Migraine/chronic headache

552 (23.0)

479 (21.9)

73 (34.3)

1.51

1.06

2.16

Lombalgia

382 (15.9)

339 (15.5)

43 (20.2)

1.13

0.70

1.82

Irritative urinary symptoms

373 (15.6)

319 (14.6)

54 (25.4)

1.84

1.38

2.46

Constipation

482 (20.1)

443 (20.3)

39 (18.3)

0.89

0.64

1.24

Distension

937 (39.1)

824 (37.7)

113 (53.0)

1.77

1.37

2.29

IBS criteria

283 (11.8)

220 (10.1)

63 (29.6)

3.14

2.40

4.10

Bristol scale

      

 Types 1–2

675 (28.2)

612 (28.0)

63 (29.6)

1.05

0.80

1.40

 Types 3–4–5

1650 (68.9)

1503 (68.9)

146 (68.5)

1.00

1.00

1.00

 Types 6–7

71 (3.0)

67 (3.1)

4 (1.9)

0.64

0.24

1.67

Sleep disturbance

654 (27.3)

529 (24.2)

125 (58.7)

2.61

1.86

3.65

SRQ >  = 8

425 (17.7)

352 (16.1)

73 (34.3)

2.30

1.63

3.24

  1. CI confidence interval; PR prevalence ratio; IBS irritable bowel syndrome; SRQ self report questionnaire (used for screening mental disorders)